Malignant minor salivary gland carcinomas of the larynx.
OBJECTIVE
To explore the clinical characteristics and treatment of malignant minor salivary gland carcinomas of the larynx.


METHODS
Clinical patient information regarding presentation, pathology, treatment and outcome was obtained through a review of patient charts.


RESULTS
Malignant minor salivary carcinomas in the larynx were confirmed pathologically in 15 patients (11 males, 4 females) between 2003 and 2010 in our hospital; 6 patients had mucoepidermoid carcinoma (MEC; 40%), 6 had adenoid cystic carcinoma (ACC; 40%) and 3 had adenocarcinoma (20%). The most common tumour location was the subglottis (60%), followed by the supraglottis (33%). In total, 13 patients underwent surgery, of which 10 (77%) had positive/insufficient resection margins. The mean follow-up time was 42.3 months, with a range of 8-129 months. The 3- and 5-year overall survival rates were 46.7 and 20%, respectively.


CONCLUSIONS
Malignant minor salivary gland carcinoma of the larynx is a rare disease that showed male predominance in our study. The carcinomas were most often localised in the subglottic region, and the most common histological types were ACC and MEC. Wide-margin surgery with postoperative radiotherapy is advocated. The overall prognosis is poor compared to squamous cell carcinomas of the same location and tumour stage.
Department of Otolaryngology, Eye, Ear, Nose and Throat Hospital, Fudan University, Shanghai, PR China.
Ming
M
Zhang
Ke-Nan
KN
Li
Cai
C
Li
Liang
L
Zhou
Jia-Xing
JX
Zhu
Shu-Yi
SY
Wang
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002294:Carcinoma, Squamous Cell / Q000473:pathology* / Q000628:therapy; D005260:Female; D006801:Humans; D007822:Laryngeal Neoplasms / Q000473:pathology* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012468:Salivary Gland Neoplasms / Q000473:pathology* / Q000628:therapy; D012470:Salivary Glands, Minor / Q000473:pathology; D016019:Survival Analysis